Dosing Sample Clauses
Dosing. Company shall not exceed the maximum allowable dosing levels of Captisol specified in CyDex’s then-current clinical dosing matrix (which shall be provided by CyDex to Company from time to time) without the written consent of CyDex.
Dosing. Company shall not exceed the maximum allowable dosing levels of Captisol specified in Exhibit E hereto without the written consent of CyDex.
Dosing. Sage shall not exceed the dosing matrix levels of Captisol indicated by Exhibit E hereto without the written consent of CyDex.
Dosing. 5.8.4 Side effects. 5.8.5 Drug interactions especially with alcohol and benzodiazepines.
Dosing. Except as agreed to by the FDA or an equivalent foreign regulatory agency or body, Seelos shall not exceed the maximum allowable dosing levels of Captisol specified in CyDex’s then-current clinical dosing matrix (which shall be provided by CyDex to Seelos from time to time) without the written consent of CyDex, which consent shall not be unreasonably withheld or delayed.
Dosing. Appropriate prescribing for patients on more than one medication;
Dosing. One hundred mM solutions of NH, 2-MeNH iodide, THNH, and 4-phenylpyridine (4PP) (table 2.3) were diluted in media to 2000 µM for 2-MeNH iodide (20 µL of solution in 1 mL of media), 800 µM (8 µL of solution in 1 mL of media) for NH and 1600 µM (16 µL of solution in 1 mL of media) for THNH and 4PP. Each dilution was pipetted directly into the top well of a v-bottomed, 96 deep-well block (Starlab, ▇▇▇▇▇▇ Keynes, UK) as shown in figure 2.4.
Dosing. The posaconazole suspension is indicated to be dosed as 200 mg TID for prophylaxis or as 400 mg BID or 200 mg QID for treatment of refractory IFDs or for treatment of patients with IFD who are intolerant to first line therapy. The delayed-release tablet and intravenous formulation are indicated to be given as a loading dose at 300 mg BID on the first day and a maintenance dose at 300 mg QD thereafter.
Dosing. Sage shall not exceed the dosing matrix levels of Captisol indicated by Exhibit E hereto without the written consent of CyDex. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. EXECUTION COPY